Calcified Tissue International

, Volume 75, Issue 5, pp 405–415

Effects of Strontium on the Physicochemical Characteristics of Hydroxyapatite

  • S. C. Verberckmoes
  • G. J. Behets
  • L. Oste
  • A. R. Bervoets
  • L. V. Lamberts
  • M. Drakopoulos
  • A. Somogyi
  • P. Cool
  • W. Dorriné
  • M. E. De Broe
  • P. C. D’Haese
Article

Abstract

In a previous experimental study using a chronic renal failure rat model, a dose-related multiphasic effect of strontium (Sr) on bone formation was found that could be reproduced in an in vitro set-up using primary rat osteoblasts. The results from the latter study allowed us to distinguish between a reduced nodule formation in the presence of an intact mineralization at low Sr-doses (1  Μg/ml) and an interference of the element with the hydroxyapatite (HA) formation at high doses (20–100  Μg/ml). To further investigate the latter effect of Sr on physicochemical bone mineral properties, an in vitro study was set up in which the UMR-106 rat osteosarcoma cell line was exposed to Sr, added to the cell culture medium in a concentration range varying between 0–100  Μg/ml. Temporal growth and functionality of the culture was investigated by measurement of the alkaline phosphatase activity and calcium (Ca) concentration in the culture medium (used as an index of Ca-incorporation, i.e., HA formation) at various time points. At the end of the culture period (14 days post-confluence), samples of the mineralized cultures were taken for further analysis using X-ray diffraction (XRD) and Fourier Transform Infra-Red Spectroscopy (FTIR). Synthetic HA doped with various Sr concentrations (based on the cell culture and previous experimental studies and yielding Sr/(Sr+Ca) ratios ranging from 0–60%), was prepared and examined for crystal growth and solubility. Crystal size was assessed using scanning electron microscopy (SEM). Ca incorporation indicated a reduced mineralization in the 20 and 100  Μg/ml Sr groups vs. controls. Sr-doped synthetic HA showed a significant dose-dependent reduction in crystal growth, as assessed by SEM, and an increase in solubility, apparent from 12.7% Sr/(Sr+Ca) on. Moreover, in both mineralized cultures and synthetic HA, XRD and FTIR analysis showed a reduced crystallinity and altered crystal lattice at similar concentrations. These new data support our previous in vivo and in vitro findings and point to a potential physicochemical interference of Sr with HA formation and crystal properties in vivo.

Keywords

Strontium Hydroxyapatite X-ray diffraction Mineralization Cell culture 

References

  1. 1.
    Rosenthal, HL, Eves, MM, Cochran, OA 1970Common strontium concentration of mineralized tissues from marine and sweet water animalsComp Biochem Physiol32445450CrossRefPubMedGoogle Scholar
  2. 2.
    Schroeder, HA, Tipton, IH, Nason, AP 1972Trace metals in man: strontium and bariumJ Chronic Dis25491517CrossRefPubMedGoogle Scholar
  3. 3.
    Rosenthal, HL, Cochran, OA, Eves, MM 1972Strontium content of mammalian bone, diet and excretaEnviron Res5182191PubMedGoogle Scholar
  4. 4.
    Skoryna, SC 1984Metabolic aspects of the pharmacologic uses of the trace elements in human subjects with specific reference to stable strontiumTrace Subst Environ Health18323Google Scholar
  5. 5.
    Grynpas, MD, Hamilton, E, Cheung, R, Tsouderos, Y, Deloffre, P, Hott, M, Marie, PJ 1996Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defectBone18253259CrossRefPubMedGoogle Scholar
  6. 6.
    Marie, PJ, Garba, MT, Hott, M, Miravet, L 1985Effect of low doses of stable strontium on bone metabolism in ratsMiner Electrolyte Metab11513PubMedGoogle Scholar
  7. 7.
    Marie, PJ, Hott, M, Modrowski, D, Pollak, C, Guillemain, J, Deloffre, P, Tsouderos, Y 1993An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient ratsJ Bone Miner Res8607615PubMedGoogle Scholar
  8. 8.
    Matsumoto, A 1988Effect of strontium chloride on bone resorption induced by prostaglandin E2 in cultured boneArch Toxicol62240241PubMedGoogle Scholar
  9. 9.
    Omdahl, JL, DeLuca, HF 1972Rachitogenic activity of dietary strontium. I. Inhibition of intestinal calcium absorption and 1,25-dihydroxycholecalciferol synthesisJ Biol Chem24755205526PubMedGoogle Scholar
  10. 10.
    Omdahl, JL, DeLuca, HF 1971Strontium-induced rickets: metabolic basisScience174949951PubMedGoogle Scholar
  11. 11.
    Ozgur, S, Sumer, H, Kocoglu, G 1996Rickets and soil strontiumArch Dis Child75524526PubMedGoogle Scholar
  12. 12.
    Schrooten, I, Behets, GJ, Cabrera, W, Vercauteren, SR, Lamberts, LV, Verberckmoes, SC, Bervoets, AJ, Dams, G, Goodman, WG, Broe, ME, D’Haese, PC 2003Dose-dependent effects of strontium on bone of chronic renal failure ratsKidney Int63927935CrossRefPubMedGoogle Scholar
  13. 13.
    Schrooten, I, Cabrera, W, Goodman, WG, Dauwe, S, Lamberts, LV, Marynissen, R, Dorrine, W, Broe, ME, D’Haese, PC 1998Strontium causes osteomalacia in chronic renal failure ratsKidney Int54448456CrossRefPubMedGoogle Scholar
  14. 14.
    Grynpas, MD, Marie, PJ 1990Effects of low doses of strontium on bone quality and quantity in ratsBone11313319CrossRefPubMedGoogle Scholar
  15. 15.
    Meunier, PJ, Reginster, JY 2003Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosisOsteoporos Int146676Google Scholar
  16. 16.
    Meunier, PJ, Slosman, DO, Delmas, PD, Sebert, JL, Brandi, ML, Albanese, C, Lorenc, R, Pors-Nielsen, S, Vernejoul, MC, Roces, A, Reginster, JY 2002Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis–a 2-year randomized placebo-controlled trialJ Clin Endocrinol Metab8720602066CrossRefPubMedGoogle Scholar
  17. 17.
    Reginster, JY, Meunier, PJ 2003Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studiesOsteoporos Int145665CrossRefGoogle Scholar
  18. 18.
    Reginster, JY 2002Strontium ranelate in osteoporosisCurr Pharm Des819071916PubMedGoogle Scholar
  19. 19.
    Verberckmoes, SC, Broe, ME, D’Haese, PC 2003Dose-dependent effects of strontium on osteoblast function and mineralizationKidney Int64534543CrossRefPubMedGoogle Scholar
  20. 20.
    Tietz, NW, Rinker, AD, Shaw, LM 1983IFCC methods for the measurement of catalytic concentration of enzymes Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1)J Clin Chem Clin Biochem21731748PubMedGoogle Scholar
  21. 21.
    Hansen, AC 1973Atomic absorption spectrophotometry for calcium and magnesium in serum and urineAbsorption Newslett12125128Google Scholar
  22. 22.
    D’Haese, PC, Landeghem, GF, Lamberts, LV, Bekaert, VA, Schrooten, I, Broe, ME 1997Measurement of strontium in serum, urine, bone, and soft tissues by Zeeman atomic absorption spectrometryClin Chem43121128PubMedGoogle Scholar
  23. 23.
    Sun, J, Xue, M, Kikuchi, M, Akao, M, Aoki, H 1994Effects of Sr-hydroxyapatite microcrystal on cultured cellBiomed Mater Eng4503512PubMedGoogle Scholar
  24. 24.
    Christoffersen, J, Christoffersen, MR, Kolthoff, N, Barenholdt, O 1997Effects of strontium ions on growth and dissolution of hydroxyapatite and on bone mineral detectionBone204754CrossRefPubMedGoogle Scholar
  25. 25.
    Fiske, CH, Subbarow, Y 1925The colorimetric determination of phosphorusJ Biol Chem66375Google Scholar
  26. 26.
    Wess, T, Alberts, I, Hiller, J, Drakopoulos, M, Chamberlain, AT, Collins, M 2002Microfocus small angle X-ray scattering reveals structural features in archaeological bone samples: detection of changes in bone mineral habit and sizeCalcif Tissue Int70103110CrossRefPubMedGoogle Scholar
  27. 27.
    Somogyi, A, Drakopoulos, M, Vincze, L, Vekemans, B, Camerani, C, Janssens, K, Snigirev, A, Adams, F 2001ID18F: a new micro-X-ray fluorescence end-station at the European Synchrotron Radiation Facility (ESRF) preliminary resultsX-ray Spectrometry30242252Google Scholar
  28. 28.
    Hammersley, AP, Svensson, SO, Hanfland, M, Fitch, AN, Hausermann, D 1996Two-dimensional detector software: from real detector to idealised image or two-theta scan high pressureResearch14235248Google Scholar
  29. 29.
    Schneider, GB, Zaharias, R, Stanford, C 2001Osteoblast integrin adhesion and signaling regulate mineralizationJ Dent Res8015401544PubMedGoogle Scholar
  30. 30.
    Stanford, CM, Jacobson, PA, Eanes, ED, Lembke, LA, Midura, RJ 1995Rapidly forming apatitic mineral in an osteobiastic cell line (UMR 106- 01 BSP)J Biol Chem27094209428CrossRefPubMedGoogle Scholar
  31. 31.
    Chak, CW, Lee, KM, Leung, KS, Fung, KP 1995No change in bone-specific alkaline phosphatase activities in cultured rat osteoblastic cells under L-ascorbate and beta-glycerophosphate-induced mineralizationCell Biol Int19979985CrossRefPubMedGoogle Scholar
  32. 32.
    Marie, PJ, Ammann, P, Boivin, G, Rey, C 2001Mechanisms of action and therapeutic potential of strontium in boneCalcif Tissue Int69121129CrossRefPubMedGoogle Scholar
  33. 33.
    Boivin, G, Deloffre, P, Perrat, B, Panczer, G, Boudeulle, M, Mauras, Y, Allain, P, Tsouderos, Y, Meunier, PJ 1996Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administrationJ Bone Miner Res1113021311PubMedGoogle Scholar
  34. 34.
    Dahl, SG, Allain, P, Marie, PJ, Mauras, Y, Boivin, G, Ammann, P, Tsouderos, Y, Delmas, PD, Christiansen, C 2001Incorporation and distribution of strontium in boneBone28446453CrossRefPubMedGoogle Scholar
  35. 35.
    Paschalis, EP, Betts, F, DiCarlo, E, Mendelsohn, R, Boskey, AL 1997FTIR microspectroscopic analysis of human iliac crest biopsies from untreated osteoporotic boneCalcif Tissue Int61487492CrossRefPubMedGoogle Scholar
  36. 36.
    Paschalis, EP, Betts, F, DiCarlo, E, Mendelsohn, R, Boskey, AL 1997FTIR microspectroscopic analysis of normal human cortical and trabecular boneCalcif Tissue Int61480486CrossRefPubMedGoogle Scholar
  37. 37.
    Boivin, G, Meunier, PJ 2003The mineralization of bone tissue: a forgotten dimension in osteoporosis researchOsteoporos Int141924CrossRefPubMedGoogle Scholar
  38. 38.
    Ryan, LM, Cheung, HS, LeGeros, RZ, Kurup, IV, Toth, J, Westfall, PR, McCarthy, GM 1999Cellular responses to whitlockiteCalcif Tissue Int65374377CrossRefPubMedGoogle Scholar
  39. 39.
    Scotchford, CA, Ali, SY 1997Association of magnesium whitlockite crystals with lipid components of the extracellular matrix in human articular cartilageOsteoarthritis Cartilage5107119PubMedGoogle Scholar
  40. 40.
    Aronow, MA, Gerstenfeld, LC, Owen, TA, Tassinari, MS, Stein, GS, Lian, JB 1990Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cellsJ Cell Physiol143213221PubMedGoogle Scholar
  41. 41.
    Bhargava, U, Bar-Lev, M, Bellows, CG, Aubin, JE 1988Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cellsBone9155163CrossRefPubMedGoogle Scholar
  42. 42.
    Nefussi, JR, Brami, G, Modrowski, D, Oboeuf, M, Forest, N 1997Sequential expression of bone matrix proteins during rat calvaria osteoblast differentiation and bone nodule formation in vitroJ Histochem Cytochem45493503PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • S. C. Verberckmoes
    • 1
  • G. J. Behets
    • 1
  • L. Oste
    • 1
  • A. R. Bervoets
    • 1
  • L. V. Lamberts
    • 1
  • M. Drakopoulos
    • 2
  • A. Somogyi
    • 2
  • P. Cool
    • 3
  • W. Dorriné
    • 3
  • M. E. De Broe
    • 1
  • P. C. D’Haese
    • 1
  1. 1.Department of Nephrology-HypertensionUniversity of AntwerpAntwerpBelgium
  2. 2.European Synchrotron Radiation FacilityGrenobleFrance
  3. 3.Department of ChemistryUniversity of AntwerpAntwerpBelgium

Personalised recommendations